| |
Disease group
|
|---|
| |
Healthy controls
|
Systemic lupus erythematosus
|
Rheumatoid arthritis
|
Inflammatory disease
|
|---|
| |
Mean
|
SEM
|
Mean
|
SEM
|
Mean
|
SEM
|
Mean
|
SEM
|
|---|
|
PD-1+ (%)
| | | | | | | | |
|
in CD3+
|
0.6
|
0.2
|
0.4
|
0.1
|
1.6
|
0.6
|
0.5
|
0.1
|
|
in CD19+
|
1.7
|
0.9
|
1.4
|
0.3
|
0.9
|
0.4
|
1.1
|
0.4
|
|
in CD25+
|
3.0
|
1.0
|
2.4
|
0.7
|
3.3
|
1.6
|
8.5
|
3.4
|
|
PD-L1+ (%)
| | | | | | | | |
|
in CD3+
|
2.8
|
1.2
|
4.1
|
0.9
|
2.3
|
0.5
|
2.0
|
0.6
|
|
in CD19+
|
3.9
|
1.3
|
5.1
|
0.9
|
3.7
|
1.0
|
11.3
|
8.0
|
|
in CD14+
|
5.1
|
2.0
|
14.0
|
5.4
|
2.9
|
0.9
|
5.7
|
3.2
|
|
PD-L2+ (%)
| | | | | | | | |
|
in CD3+
|
0.6
|
0.2
|
0.5
|
0.1
|
0.5
|
0.2
|
0.4
|
0.0
|
|
in CD14+
|
2.0
|
0.5
|
1.4
|
0.3
|
1.1
|
0.5
|
1.2
|
0.1
|
- SEM, standard error of the mean. No statistically significant differences were observed.
